Town & Country Bank & Trust CO dba First Bankers Trust CO Has $1.33 Million Stake in Danaher Corporation $DHR

Key Points

• Town & Country Bank & Trust CO reduced its stake in Danaher Corporation by 39.6% in Q2, owning 6,714 shares valued at approximately $1.33 million at the end of the reporting period.
• Danaher reported an EPS of $1.80 for the last quarter, surpassing analyst expectations, with revenue of $5.94 billion, a net margin of 14.21%, and a year-over-year revenue increase of 3.4%.
• The company announced a quarterly dividend of $0.32, with an annualized dividend yield of 0.7%, payable on October 31st to investors of record as of September 26th.

Town & Country Bank & Trust CO dba First Bankers Trust CO decreased its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 39.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,714 shares of the conglomerate's stock after selling 4,405 shares during the quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO's holdings in Danaher were worth $1,326,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. MGO One Seven LLC grew its holdings in Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after acquiring an additional 20,813 shares during the last quarter. UniSuper Management Pty Ltd boosted its stake in shares of Danaher by 1.6% in the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock valued at $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in shares of Danaher in the 1st quarter valued at $539,000. Horizon Financial Services LLC boosted its stake in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after purchasing an additional 8,160 shares during the last quarter. Finally, Focus Partners Wealth boosted its stake in shares of Danaher by 10.7% in the 1st quarter. Focus Partners Wealth now owns 196,682 shares of the conglomerate's stock valued at $40,328,000 after purchasing an additional 19,086 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 1.5%

Shares of Danaher stock opened at $190.30 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a 50-day moving average of $200.02 and a 200 day moving average of $198.03. The firm has a market cap of $136.26 billion, a price-to-earnings ratio of 40.49, a PEG ratio of 2.70 and a beta of 0.75. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the business earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio (DPR) is presently 27.23%.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Evercore ISI cut their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a report on Friday, July 11th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Finally, Guggenheim restated a "buy" rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $245.91.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.20% of the stock is currently owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.